[go: up one dir, main page]

AR013614A1 - Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento - Google Patents

Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento

Info

Publication number
AR013614A1
AR013614A1 ARP970104615A ARP970104615A AR013614A1 AR 013614 A1 AR013614 A1 AR 013614A1 AR P970104615 A ARP970104615 A AR P970104615A AR P970104615 A ARP970104615 A AR P970104615A AR 013614 A1 AR013614 A1 AR 013614A1
Authority
AR
Argentina
Prior art keywords
kit
formoterol
manufacture
debudesonida
steroids
Prior art date
Application number
ARP970104615A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR013614A1 publication Critical patent/AR013614A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composicinn o kit que tiene un primer ingrediente activo formoterol, o una sal o solvato derivado del mismo, y que tiene como un segundo ingredienteactivo budesonida, donde la razon molar del primer ingrediente activo al segundo ingrediente ativo es desde 1:30 a 1:36,; el uso de la composicion y kitpara la preparacion de medicamentos para el tratamiento de desordenes respiratorios; y el uso de formoterol y budesonida en la fabricacion demedicamentos.
ARP970104615A 1996-10-08 1997-10-07 Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento AR013614A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (sv) 1996-10-08 1996-10-08 New combination

Publications (1)

Publication Number Publication Date
AR013614A1 true AR013614A1 (es) 2001-01-10

Family

ID=20404167

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104615A AR013614A1 (es) 1996-10-08 1997-10-07 Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento

Country Status (18)

Country Link
EP (1) EP0871450A1 (es)
JP (1) JP2000502365A (es)
KR (1) KR19990071975A (es)
AR (1) AR013614A1 (es)
AU (1) AU715319B2 (es)
BR (1) BR9706822A (es)
CA (1) CA2239308A1 (es)
CZ (1) CZ176198A3 (es)
HU (1) HUP9901674A3 (es)
MY (1) MY128337A (es)
NO (1) NO982414D0 (es)
NZ (1) NZ330482A (es)
PL (1) PL327037A1 (es)
SE (1) SE9603669D0 (es)
SK (1) SK75198A3 (es)
TW (1) TW470647B (es)
WO (1) WO1998015280A1 (es)
ZA (1) ZA978889B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
CA2295076A1 (en) * 1997-06-27 1999-01-07 Astra Aktiebolag New combination of antiasthma medicaments
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
SE9900834D0 (sv) * 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
SE0200312D0 (sv) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
EP2054042B8 (en) 2006-06-30 2020-06-10 iCeutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
EP2124915A2 (en) 2007-02-19 2009-12-02 Cipla Limited Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
PL3111926T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
CA2865702C (en) * 2012-02-28 2020-04-28 Iceutica Holdings Inc. Bvi Inhalable pharmaceutical compositions
ITMI20130571A1 (it) 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
IT202000006442A1 (it) 2020-03-27 2021-09-27 Genetic S P A Budesonide 21-phosphate salts and pharmaceutical compositions containing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288032B6 (cs) * 1991-12-18 2001-04-11 Aktiebolaget Astra Farmaceutický prostředek pro podání inhalací

Also Published As

Publication number Publication date
NO982414L (no) 1998-05-27
EP0871450A1 (en) 1998-10-21
SE9603669D0 (sv) 1996-10-08
HUP9901674A2 (hu) 1999-09-28
NO982414D0 (no) 1998-05-27
ZA978889B (en) 1998-04-08
AU4578297A (en) 1998-05-05
BR9706822A (pt) 1999-03-23
AU715319B2 (en) 2000-01-20
MY128337A (en) 2007-01-31
CZ176198A3 (cs) 1998-09-16
JP2000502365A (ja) 2000-02-29
PL327037A1 (en) 1998-11-09
HUP9901674A3 (en) 2001-04-28
KR19990071975A (ko) 1999-09-27
NZ330482A (en) 1999-11-29
WO1998015280A1 (en) 1998-04-16
TW470647B (en) 2002-01-01
SK75198A3 (en) 1998-11-04
CA2239308A1 (en) 1998-04-16

Similar Documents

Publication Publication Date Title
AR013614A1 (es) Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento
ES2180592T3 (es) Formulaciones en aerosol libres de clorofluorocarbonos.
BG102689A (bg) Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
ATE216575T1 (de) Treibgasmischung für eine aerosolzubereitung
ES2182357T3 (es) Nueva utilizacion de budesonide y formoterol.
BR0008699A (pt) Combinações de formoterol e furoato demometasona para asma
AR032132A1 (es) Composicion farmaceutica que comprende una combinacion de un compuesto de tramadol y una droga anticonvulsiva y uso de la combinacion para preparar un medicamento
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
AR018410A1 (es) Uso de una composicion para la manufactura de un medicamento que se usa para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitentey/o episodios de asma cronico y metodo para la prevencion o tratamiento de un estado agudo de asma y/o asma intermitente y/o episodios de asma cron
FI935464A0 (fi) Klorfluorkolfria aerosolformulationer
MX9300620A (es) Formulacion farmaceutica en aerosol e inhalador para la administracion de dipropionato de beclometasona.
AR015820A1 (es) Particulas de budesonida, composicion farmaceutica, uso de dichas particulas para la fabricacion de medicamentos, metodo para el tratamiento de untrastorno respiratorio y proceso para la preparacion de las particulas
AR036358A1 (es) Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
BR9911071A (pt) Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido
DK0616525T3 (da) Medikamenter
BR9916829A (pt) Formulações aerossóis farmacêuticas contendo fluoroalcanos, budesonida e formoterol
PT90764A (pt) Processo para a preparacaode um produto farmaceutico compreendendo um estrogenio e um anti-estrigenio e de composicoes farmaceuticas que os contem
ATE275393T1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
ES2174199T3 (es) Utilizacion de un poliholosido para estimular las defensas inmunitarias.
ES2134634T3 (es) Composiciones farmaceuticas y dispositivos para su administracion.
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
ES2172171T3 (es) Medicamento, que contiene yohimbina y arginina, para el tratamiento de disfunciones erectiles.
DE69918961D1 (de) Verbesserte inhalationspräparate
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz

Legal Events

Date Code Title Description
FA Abandonment or withdrawal